Glooko announced new data reflecting positive outcomes using its EndoTool platform for insulin dosing. EndoTool, a leading software platform, offers capabilities for inpatient insulin dosing and glycemic management. The FDA-cleared platform delivers assistance in optimizing insulin dosing, using a patient-specific algorithm in real-time. It helps reduce the risk of hypoglycemia and helps hospitals meet CMS […]
Diabetes
Senseonics launches Eversense 365 year-long CGM in Europe
Senseonics (Nasdaq:SENS) announced today that it initiated the first European launch of its Eversense 365 continuous glucose monitor (CGM). The launch comes a few months after the company picked up CE mark for the long-term, implantable CGM in January. The year-long sensor rests under the skin, meaning it can not be knocked off, minimizing inconveniences […]
Beta Bionics increases 2026 sales guidance on 57% Q1 growth
Beta Bionics (Nasdaq:BBNX) today reported first-quarter sales results that came in ahead of the forecast on Wall Street. For the full year, the company expects sales to range between $131 million and $136 million. It previously forecast between $130 million and $135 million. Shares of Beta Bionics fell 2% to $12.03 apiece after the market […]
Gluckotrack study supports feasibility of long-term CGM implant
Glucotrack (Nasdaq:GCTK) today announced the publication of a peer-reviewed scientific article evaluating its long-term glucose sensor. The article, published in the Institute of Electrical and Electronics Engineers (IEEE) Sensors Journal, demonstrated the long-term in-vitro stability of the electrochemical glucose sensors used in the company’s fully implantable continuous blood glucose monitoring (CBGM) system. The company said […]
Abbott wins appeal for preliminary injunction against Sinocare in CGM patent spat
The Unified Patent Court (UPC) Court of Appeal granted Abbott (NYSE:ABT) a preliminary injunction in its patent battle against Sinocare. Abbott’s preliminary injunction victory means Sinocare is banned from selling its iCan i3 continuous glucose monitor (CGM) offering in UPC territory. The UPC decision overturned a prior ruling from a local division (LD) of The […]
Dexcom opens Athenry CGM manufacturing facility
Dexcom (Nasdaq:DXCM) said today that it has officially opened its manufacturing and office development in Athenry, Ireland. The San Diego-based continuous glucose monitor (CGM) maker broke ground on the facility in January 2024. It said in 2023 that it expected to invest $325 million in Athenry. Last month, an Irish construction company said it completed work […]
The first year-long CGM implant developer isn’t done yet
Senseonics VP of Product Development Hari Sree explains the tech behind the Eversense 365 continuous glucose monitor and what’s next in the pipeline.
Senseonics became the first company to bring a year-long continuous glucose monitor (CGM) to market with the launch of its Eversense 365 implantable system in 2024. The sensor system is different than existing transcutaneous sensors from Abbott and Dexcom, which use a small needle to measure glucose in the interstitial fluid under a patient’s skin […]
Abbott CEO is bullish on CGM market despite analyst concerns
Abbott (NYSE:ABT) CEO Robert B. Ford remains optimistic about the company’s opportunity in the continuous glucose monitor (CGM) market. The company reported its first-quarter earnings today, which included $2 billion in FreeStyle Libre CGM sales, growing 7.5%. Abbott noted a delay in the renewal process related to an international tender, as well as an expected […]
ViCentra makes Kaleido automated insulin pump immediately available with no waiting period
ViCentra announced today that it made its Kaleido automated insulin pump immediately available, with no waiting period to get started. Kaleido, a miniature, patch-style insulin pump, is currently available in Germany, the Netherlands and France. Once a healthcare provider has prescribed Kaleido and the prescription has been approved, users can move very quickly to receive […]
MiniMed flexes with next-gen insulin pump after spinning off from Medtronic
MiniMed Chief Product and Technology Officer Ali Dianaty explains how the former Medtronic Diabetes unit used patient feedback to develop its latest automated insulin delivery innovation.
Within two weeks of MiniMed’s initial public offering in March, the Medtronic spinoff received FDA clearance for its latest-generation MiniMed Flex automated insulin delivery system. The smaller, screenless pump system is a major milestone for one of the world’s largest diabetes businesses. “We have a long history with durable pumps,” MiniMed EVP, Chief Product and Technology Officer, Ali Dianaty said in […]
